Published in Antimicrob Agents Chemother on July 01, 1975
In vitro activity of antimicrobial agents on Legionnaires disease bacterium. Antimicrob Agents Chemother (1978) 3.11
In-use evaluation of a prediluted quantitative antibiotic susceptibility test device. Antimicrob Agents Chemother (1977) 1.91
Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains. J Clin Microbiol (1989) 1.76
A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers. Postgrad Med J (1980) 1.25
Bacteriuria caused by Acinetobacter calcoaceticus biovars in a normal population and in general practice. J Clin Microbiol (1982) 1.02
In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus. Antimicrob Agents Chemother (1979) 0.98
In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima). Antimicrob Agents Chemother (1976) 0.81
Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline. Antimicrob Agents Chemother (1976) 0.77
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Changing ecology of bacterial infections as related to antibacterial therapy. J Infect Dis (1970) 7.72
Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci (1968) 4.00
Microdilution antibiotic susceptibility test: examination of certain variables. Appl Microbiol (1973) 3.51
Moraxella, Acinetobacter, and the Mimeae. Bacteriol Rev (1973) 3.43
BACTEREMIA DUE TO GRAM-NEGATIVE RODS. A CLINICAL, BACTERIOLOGIC, SEROLOGIC AND IMMUNOFLUORESCENT STUDY. N Engl J Med (1965) 2.39
Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972. Am J Med (1974) 2.13
Serratia marcescens septicemia. A new threat in surgery. Arch Surg (1969) 2.04
Infections due to organisms of the genus Herellea. B5W and B. anitratum. Arch Intern Med (1962) 1.95
Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis (1973) 1.95
Serratia sp. infections in cancer patients. Cancer (1970) 1.73
Absorption and excretion of five tetracycline analogues in normal young men. Am J Med Sci (1968) 1.72
Serratia marcescens bacteremia. Clinical observations and studies of precipitin reactions. Arch Intern Med (1971) 1.44
In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing. Appl Microbiol (1970) 1.30
Cross-infection with Serratia marcescens in an intensive-therapy unit. Lancet (1972) 1.14
In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 5.54
Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature (1985) 4.62
Involvement of p34cdc2 in establishing the dependency of S phase on mitosis. Nature (1991) 4.60
Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 4.20
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci (1975) 4.01
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis (1982) 3.96
Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. Am J Med (1976) 3.86
Microdilution antibiotic susceptibility test: examination of certain variables. Appl Microbiol (1973) 3.51
Evaluation of rapid coagulase methods for the identification of Staphylococcus aureus. J Clin Microbiol (1986) 2.57
Evaluation of the performance parameters of a prediluted, quantitative antibiotic susceptibility test device. Antimicrob Agents Chemother (1977) 2.54
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (1996) 2.52
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother (1995) 2.49
The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J Infect Dis (1985) 2.44
Rapid detection of Clostridium difficile toxin in human feces. J Clin Microbiol (1980) 2.33
Automated reading of MIC microdilution trays containing fluorogenic enzyme substrates with the Sensititre Autoreader. J Clin Microbiol (1985) 2.20
Legionnaires' disease antigen detected by enzyme-linked immunosorbent assay. Ann Intern Med (1979) 2.11
Effect of delay on culture of urine. J Clin Microbiol (1976) 2.09
Comparative evaluation of three commercial products and counterimmunoelectrophoresis for the detection of antigens in cerebrospinal fluid. J Clin Microbiol (1984) 2.08
Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. J Infect Dis (1989) 2.08
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother (1999) 2.06
Comparison of the detection of herpes simplex virus in direct clinical specimens with herpes simplex virus-specific DNA probes and monoclonal antibodies. J Clin Microbiol (1985) 2.01
Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin. J Infect Dis (1974) 2.00
Restrict genetic susceptibility tests. Nature (1998) 1.99
The aetiological agent of cat scratch disease. Lancet (1985) 1.93
In-use evaluation of a prediluted quantitative antibiotic susceptibility test device. Antimicrob Agents Chemother (1977) 1.91
Clinical and ecological characteristics of Vibrio vulnificus in the northeastern United States. Diagn Microbiol Infect Dis (1987) 1.86
Isolation of Vibrio alginolyticus from wound infections. J Clin Microbiol (1975) 1.83
T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors. Immunol Rev (1980) 1.78
Synergy of carbenicillin and gentamicin in experimental infection with Pseudomonas. J Infect Dis (1971) 1.77
In vitro antibacterial activity of a new 1-oxa cephalosporin compound. Yale J Biol Med (1980) 1.70
Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res (1979) 1.70
The fission yeast SPB component Cut12 links bipolar spindle formation to mitotic control. Genes Dev (1998) 1.70
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother (1996) 1.68
Coagulase-negative staphylococcus. Ann N Y Acad Sci (1970) 1.68
Overwhelming sepsis associated with group A beta hemolytic streptococci. J Bone Joint Surg Am (1971) 1.66
Current concepts in cryptococcosis. Eur J Clin Microbiol Infect Dis (1989) 1.65
Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model. J Infect Dis (1988) 1.65
Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dyn (1994) 1.64
Gram-negative bacillary meningitis. Am J Med (1975) 1.64
Development of meningitis during cephalothin therapy. Ann Intern Med (1973) 1.62
The fission yeast gene pmt1+ encodes a DNA methyltransferase homologue. Nucleic Acids Res (1995) 1.55
Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers. J Antimicrob Chemother (1989) 1.55
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53
Automated direct antimicrobial susceptibility testing of microscopically screened urine cultures. J Clin Microbiol (1980) 1.51
Rapid method for determining the minimum inhibitory concentration of ampicillin for Haemophilus influenzae. Antimicrob Agents Chemother (1977) 1.51
Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am (1997) 1.51
Rapid detection of Chlamydia trachomatis by an enzyme immunoassay method. Diagn Microbiol Infect Dis (1986) 1.50
Leukotactic dystunction in sarcoidosis. Ann Intern Med (1976) 1.50
Pericytes, like vascular smooth muscle cells, are immunocytochemically positive for cyclic GMP-dependent protein kinase. Microvasc Res (1984) 1.48
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn Microbiol Infect Dis (1995) 1.48
Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J Antimicrob Chemother (1984) 1.47
Optimal therapy for enterococcal endocarditis. Am J Med (1984) 1.46
The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am (1977) 1.45
Evaluation of an automated agar plate streaker. J Clin Microbiol (1978) 1.45
The relationship between basketball shooting kinematics, distance and playing position. J Sports Sci (1996) 1.44
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model. J Antimicrob Chemother (1985) 1.44
Contractile proteins in pericytes. I. Immunoperoxidase localization of tropomyosin. J Cell Biol (1985) 1.44
Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci (2000) 1.43
Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am (1997) 1.43
Contractile proteins in pericytes. II. Immunocytochemical evidence for the presence of two isomyosins in graded concentrations. J Cell Biol (1985) 1.43
Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis. Am J Med (1982) 1.42
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
EDTA: a promoter of proliferation in human corneal endothelium. Invest Ophthalmol Vis Sci (2000) 1.41
Absorption of vancomycin. Ann Intern Med (1984) 1.40
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis. Antimicrob Agents Chemother (1991) 1.39
Interpreting tuberculosis skin tests. Lancet (1996) 1.39
Transplantation of adult human corneal endothelium ex vivo: a morphologic study. Cornea (2001) 1.39
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks. J Clin Microbiol (1985) 1.38
Regulation of VanA- and VanB-type glycopeptide resistance in enterococci. Antimicrob Agents Chemother (2001) 1.38
The laboratory approach to the detection of bacteremia. Annu Rev Microbiol (1982) 1.37
Micropore filter assay of human granulocyte locomotion: problems and solutions. Clin Immunol Immunopathol (1978) 1.36
Combination therapy in experimental invasive aspergillosis. J Infect Dis (1993) 1.36
Serum-associated inhibition of leukotaxis in humans with cancer. Clin Immunol Immunopathol (1978) 1.35
Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother (1990) 1.34
A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions. J Pharm Sci (1986) 1.34
The association of bacteremic Haemophilus influenzae pneumonia in adults with typable strains. Am J Med (1971) 1.34
Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers. Antimicrob Agents Chemother (1991) 1.33
Defective regulation of chemotaxis in cirrhosis. J Lab Clin Med (1975) 1.32
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa. J Pharmacokinet Biopharm (1988) 1.32
Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. Circulation (1999) 1.32
Bacteriuria in pregnancy. Infect Dis Clin North Am (1987) 1.32
Impact of thymus on the generation of immunocompetence and diversity of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors. Immunol Rev (1981) 1.31
Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease. J Clin Microbiol (1986) 1.31
Collaborative clinical evaluation of the Autobac IDX system for identification of gram-negative bacilli. J Clin Microbiol (1984) 1.30
The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. J Infect Dis (1991) 1.29
Chloramphenicol: A review of its use in clinical practice. Rev Infect Dis (1981) 1.27
An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. J Lab Clin Med (1971) 1.27
A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers. Postgrad Med J (1980) 1.25
Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med (1984) 1.25
Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob Agents Chemother (1993) 1.25
The effect and critical duration of increased tissue pressure on susceptibility to bacterial infection. Br J Exp Pathol (1965) 1.25
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. Int J Antimicrob Agents (1999) 1.24
Antibiotic sensitivities of nonpigmented serratia marcescens to gentamicin and carbenicillin. J Infect Dis (1969) 1.24
Clinical experience on the detection of endotoxemia with the limulus test. J Infect Dis (1973) 1.24
Carbenicillin: clinical and laboratory studies. J Infect Dis (1970) 1.23
Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies. J Clin Microbiol (1983) 1.23